NGL Fine-Chem Ltd. (NGLFINE): NGL Fine-Chem Share Price Rises 8.3% as Stock Draws Attention in Healthcare

NGL Fine-Chem Share Price is in focus today after the stock rose 8.3% to Rs 2,912.15, adding Rs 223.20 from the previous close of Rs 2,688.95. The company’s market capitalisation stands at Rs 1,654.04 crore, placing this move in the context of a mid-sized healthcare name rather than a broad-market heavyweight. According to latest Univest data, the stock moved between Rs 2,682 and Rs 2,940 during the day, with turnover of Rs 1.09 crore.

The latest Univest figures confirm a clear same-day share price gain, but they do not establish a company-specific catalyst. That makes the move a stock analysis story rather than a headline driven by a verified event trigger. For readers tracking NGL Fine-Chem Share Price Today, the immediate question is whether the move is being supported by the company’s valuation profile, operating quality and sector positioning. In Univest, this sort of price rise is best read alongside market capitalisation, earnings ratios and the pharma peer set.

NGL Fine-Chem Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 2,912.15
Previous Close	Rs 2,688.95
Today's Move	Rs 223.2 (+8.3%)
Open	Rs 2,755.2
High	Rs 2,940
Low	Rs 2,682
Turnover	Rs 1.09 crore
Market Capitalisation	Rs 1,654.04 crore
Market Cap Category	Small Cap

NGL Fine-Chem Ltd. (NGLFINE) rose to Rs 2,912.15 from the previous close of Rs 2,688.95, a move of Rs 223.2 or 8.3%. The stock opened at Rs 2,755.2, reached a high of Rs 2,940, recorded a low of Rs 2,682.

NGL Fine-Chem Share Price Today showed strong intraday buying interest. The stock opened at Rs 2,755.20, moved as low as Rs 2,682 and touched a high of Rs 2,940 before trading near Rs 2,912.15. That places the current move well above the previous close and close to the day’s upper band, which is why NGLFINE is showing up in Stocks in News and Top Gainers Today screens on Market News feeds. For investors watching NGL Fine-Chem Share Price Live, the main takeaway is simple: the stock is rising today on verified price action, while the reason behind the move remains unconfirmed. Univest data confirms the event, not the trigger.

NGL Fine-Chem Ltd. (NGLFINE) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 1,654.04 crore
P/E Ratio	29.04x
P/B Ratio	4.78x
ROE	15.74%
ROCE	16.88%
EPS	Rs 92.59
Book Value Per Share	Rs 562.7
Dividend Yield	0.07%

NGL Fine-Chem Ltd. (NGLFINE) fundamental metrics show P/E 29.04x, P/B 4.78x, ROE 15.74%, ROCE 16.88%. These figures provide context only and are not a buy or sell signal.

NGL Fine-Chem Ltd. has a market capitalisation of Rs 1654.04 crore and falls in the Small Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 29.04x, P/B at 4.78x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 15.74% and ROCE of 16.88%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 92.59, book value per share of Rs 562.7, dividend yield of 0.07%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.97x, median ROE of 11.79%, median ROCE of 13.63%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	29.04x
Benchmark Median P/E	31.97x
Benchmark Average P/E	48.6x
Benchmark P/E Range	3.49x to 648.54x
Company P/B Ratio	4.78x
Benchmark Median P/B	2.87x
Company ROE	15.74%
Benchmark Median ROE	11.79%
Company ROCE	16.88%
Benchmark Median ROCE	13.63%
Company Market Capitalisation	Rs 1,654.04 crore
Benchmark Median Market Cap	Rs 727.27 crore

NGL Fine-Chem Ltd. (NGLFINE) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

NGL Fine-Chem Ltd. (NGLFINE) has a P/E ratio of 29.04x, which is below the benchmark median of 31.97x, a difference of -9.16%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

NGL Fine-Chem Ltd. (NGLFINE) has a ROE of 15.74%, which is above the benchmark median of 11.79%, a difference of +33.5%. NGL Fine-Chem Ltd. (NGLFINE) has a ROCE of 16.88%, which is above the benchmark median of 13.63%, a difference of +23.84%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sun Pharmaceutical Industries Ltd.	SUNPHARMA	4,63,179.62	38.34	5.36	14.85	19.11
Divi's Laboratories Ltd.	DIVISLAB	2,43,301.95	83.79	13.88	16.19	21.51
Torrent Pharmaceuticals Ltd.	TORNTPHARM	1,88,622.52	87.28	21.21	26.76	19.27
Zydus Lifesciences Ltd.	ZYDUSLIFE	1,16,114.43	25.44	4.26	19.69	21.39
Cipla Ltd.	CIPLA	1,14,554.33	33.87	3.25	11.83	16

NGL Fine-Chem Ltd. (NGLFINE) has a P/E ratio of 29.04x compared with the displayed peer median of 38.34x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 15.74% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 16.88% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. NGL Fine-Chem Ltd. (NGLFINE) has a market capitalisation of Rs 1,654.04 crore. Among the 5 peers shown, 5 have a larger market capitalisation.

Why Investors Are Watching NGL Fine-Chem

• NGL Fine-Chem Share Price rose 8.3% today, making it a notable market mover in Healthcare.
• The stock traded at Rs 2,912.15 after moving between Rs 2,682 and Rs 2,940 during the day.
• Its P/E of 29.04 and P/B of 4.78 frame the current valuation discussion in Univest.
• ROE of 15.74% and ROCE of 16.88% give the stock a solid profitability backdrop versus the industry benchmark.
• Sector and peer comparison show a smaller company with return ratios that remain relevant for stock analysis.

About NGL Fine-Chem

NGL Fine-Chem Ltd. belongs to the Pharmaceuticals & Drugs industry in the Healthcare sector. The company is tracked on both NSE and BSE, and its share price is followed by investors looking at specialised pharma and healthcare businesses. Based on the latest Univest figures, the stock’s market capitalisation is Rs 1,654.04 crore, which places it in the mid-cap range inside a broad industry that includes large domestic and export-oriented pharmaceutical names.

For readers following NGL Fine-Chem Company News, the business profile matters because the stock is not being judged only by a one-day price rise. It is being viewed through the lens of earnings efficiency, valuation and industry placement. That is why NGL Fine-Chem Share Price often attracts interest from those comparing NGL Fine-Chem Stock Performance with other healthcare names. In Univest, the company overview is most useful when read together with fundamentals, sector context and peer valuation rather than in isolation.

Frequently Asked Questions

Why did NGL Fine-Chem Share Price rise today?

Ans. NGL Fine-Chem Share Price rose 8.3% today, but the verified market data does not establish a company-specific catalyst. The move is confirmed by price action, opening at Rs 2,755.20 and trading near Rs 2,912.15.

What is NGL Fine-Chem Share Price today?

Ans. NGL Fine-Chem Share Price today is Rs 2,912.15. The stock added Rs 223.20 from the previous close of Rs 2,688.95, which kept it among the stronger movers in the healthcare space.

How much did NGL Fine-Chem stock gain today?

Ans. NGL Fine-Chem stock gained 8.3% today. That move came with a day range of Rs 2,682 to Rs 2,940, showing strong intraday interest around the current price level.

What is the market capitalisation of NGL Fine-Chem?

Ans. NGL Fine-Chem has a market capitalisation of Rs 1,654.04 crore. This places the company above the sector median market cap, while still below the larger pharmaceuticals names in its peer group.

How does NGL Fine-Chem look on valuation?

Ans. NGL Fine-Chem trades at a P/E of 29.04 and a P/B of 4.78. Its P/E is below the industry median of 31.97, while its P/B is above the median of 2.87.

Are NGL Fine-Chem’s returns strong versus the sector?

Ans. NGL Fine-Chem reports ROE of 15.74% and ROCE of 16.88%. Both are above the same-industry benchmark median, which gives the stock a healthier return profile than many peers.

What do EPS, book value and dividend yield show for NGL Fine-Chem?

Ans. EPS is Rs 92.59, book value is Rs 562.7 and dividend yield is 0.07%. Together, they help explain earnings support, balance-sheet backing and payout context for the share price.

How does NGL Fine-Chem compare with pharma peers?

Ans. NGL Fine-Chem is smaller than Sun Pharma, Divi’s Laboratories and Torrent Pharmaceuticals, but its ROE and ROCE compare reasonably well. That peer view helps investors place the share price rise in context.

Track NGL Fine-Chem Share Price on Univest

Use NGL Fine-Chem Ltd. (NGLFINE) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

Users can track NGL Fine-Chem Share Price on Univest for live price updates, key financial ratios, market capitalisation, 52-week levels and broader stock insights. Univest also helps readers follow NGL Fine-Chem Share Price Today alongside valuation, sector context and company news, all in one place.